Alemtuzumab, fludarabine, cyclophosphamide, and doxorubicin (campath-FCD): An effective first-line treatment in peripheral T-cell lymphomas

Weidmann, E. and Hess, G. and Krause, S. and Hebart, H. and Dreyling, M. and Subklewe, M. and Falge, C. and Atmaca, A. and Jaeger, E. and Mitrou, P. (2005) Alemtuzumab, fludarabine, cyclophosphamide, and doxorubicin (campath-FCD): An effective first-line treatment in peripheral T-cell lymphomas. In: 9th International Conference on Malignant Lymphoma, June 09-11, 2005, Lugano, Switzerland.

Full text not available from this repository.
Item Type: Conference or Workshop Item (UNSPECIFIED)
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie)
Depositing User: Petra Gürster
Date Deposited: 14 Apr 2022 06:33
Last Modified: 14 Apr 2022 06:33
URI: https://pred.uni-regensburg.de/id/eprint/36017

Actions (login required)

View Item View Item